| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |